Nearmedic Plus LLC: Clinical Trials

9 trials sponsored by Nearmedic Plus LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 terminated. 2 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Not applicable1Completed 1
Phase 21Terminated 1

Follow Nearmedic Plus LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169
PBTZ169 640 mg OD, PBTZ169 640 mg BiD, PBTZ169 960 mg SD - Healthy Subjects
Phase 1CompletedNearmedic Plus LLC602018-07-032020-02-28
Kagocel® for the Prevention of ARVI and Influenza in Young People
Kagocel, No one - Acute Upper Respiratory Tract Infection, Influenza
CompletedNearmedic Plus LLC752018-02-152020-11-12
Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
Kagocel+Valacyclovir, Valacyclovir - Herpes, Herpes Simplex
CompletedNearmedic Plus LLC452017-10-302020-12-11
Effectiveness and Safety of Collagen Complex COLLOST in Anti-age Therapy
Collagen for injections 7%, Hyaluronic acid for injections 2% - Skin Aging
Not applicableCompletedNearmedic Plus LLC602017-10-252018-09-19
Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers
Kagocel, No one - Acute Upper Respiratory Tract Infection, Influenza
CompletedNearmedic Plus LLC2042017-10-022020-11-02
Phase 2a Study of PBTZ169
PBTZ169, Isoniazid - Tuberculosis
Phase 2TerminatedNearmedic Plus LLC162016-12-162020-03-09
Phase 1 Study of PBTZ169
PBTZ169 - 40 mg, PBTZ169 - 80 mg, PBTZ169 - 160 mg - Tuberculosis
Phase 1CompletedNearmedic Plus LLC402016-01-012020-04-13
Treatment of Influenza and ARVI in Children by Kagocel ®
Kagocel - Influenza, Acute Upper Respiratory Infection
CompletedNearmedic Plus LLC802015-09-112020-12-03
Treatment of Influenza in Routine Clinical Practice
Kagocel - Influenza, Acute Upper Respiratory Infection
CompletedNearmedic Plus LLC189462013-12-012017-02-17

Conditions studied

Influenza, Human (4)  ·  Tuberculosis (3)  ·  Common Cold (2)  ·  Extensively Drug-Resistant Tuberculosis (1)  ·  Herpes Genitalis (1)  ·  Herpes Simplex (1)  ·  Tuberculosis, Multidrug-Resistant (1)

Interventions

macozinone (3)  ·  BID protein, human (1)  ·  Isoniazid (1)  ·  Valacyclovir (1)

Countries

Russia (7)  ·  Armenia (1)  ·  Georgia (1)  ·  Moldova (1)

Top investigators

Anna Stenko, PhD (1)  ·  Elena Tikhonova, Dr. habilitated, Professor (1)  ·  Georgy Vikulov, Ph.D (1)  ·  Irina Babachenko, Professor, Dr. habilitated (1)  ·  Ivan Sitnikov, Professor (1)  ·  Vladimir Petrov, Dr. habilitated, Professor (1)

Results publications

PMID 28005034